Overview

Aggressive Antipyretics for Fever Reduction in CNS Malaria

Status:
Recruiting
Trial end date:
2022-06-30
Target enrollment:
Participant gender:
Summary
The study will examine whether prophylactic and scheduled treatment with acetaminophen and ibuprofen can decrease the maximum temperature experienced during the acute illness in children with CNS malaria.
Phase:
Phase 2
Details
Lead Sponsor:
University of Rochester
Collaborator:
National Institute of Neurological Disorders and Stroke (NINDS)
Treatments:
Acetaminophen
Antipyretics
Ibuprofen